mgr Mateusz Blukacz wraz z dr inż. Karolina Strzebońska (Research Ethics in Medicine Study Group (REMEDY), Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland), dr Mateusz Wasylewski (Research Ethics in Medicine Study Group (REMEDY), Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland), dr Maciej Polak (Research Ethics in Medicine Study Group (REMEDY), Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland), dr Bishal Gyawali (Department of Oncology and the Department of Public Health Sciences, Queen’s University, Kingston, Ontario, Canada), dr hab. Marcin Waligóra, prof. UJ (Research Ethics in Medicine Study Group (REMEDY), Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland) opublikowali artykuł pt. „Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis” w czasopiśmie BMC Medicine
Więcej o artykule:
Strzebonska, K., Blukacz, M., Wasylewski, M.T., et al. Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis. BMC Med 20, 219 (2022). https://doi.org/10.1186/s12916-022-02420-2 Impact Factor: 11.150; MEiN: 200p.